PROMOTING ACCESS TO AFRICAN RESEARCH

Nigerian Journal of Clinical Practice

Log in or Register to get access to full text downloads.

Remember me or Register



Experimental investigation of relationship between trauma and bisphosphonate-related osteonecrosis

KS Agaçayak, H Yuksel, S Atilgan, M Koparal, MC Uçan, M Özgöz, F Yaman, Y Atalay, I Acikan

Abstract


Background: Bisphosphonate (BP)-related osteonecrosis of the jaw (BRONJ) disease is rare, but there are serious side-effects of BP therapy in patients. In some patients, surgery is needed and could not be cured. Astandard test is not available showing the risk of jaw osteonecrosis in routine use. The measurement of serum C.terminal telopeptide (CTX) levels has been used in diseases of BRONJ resorption and antiresorptive therapy.

Aim: This paper is aimed at investigating the relationship between  traumatic procedures and presence of BP-related osteonecrosis.

Materials and Methods: Thirty male Wistar albino rats with weighing 200 } 20 g were used for the experimental procedures. Rats were randomly divided into three groups each containing 10 rats as follows: Group 1 (traumatic extraction group), Group 2 (atraumatic extraction group), and Group 3 (control group). All groups, zoledronic acid (ZA) (0.3  mg/kg/week)[1] was diluted with physiological saline and given  subcutaneously for 2 months. After the 2 months, Group 1 was subjected to
traumatic extraction of right first lower molars, and Group 2 was subjected to atraumatic extractions of the right first lower molars. Group 3 was subjected to no extractions as a control group. Animals were euthanized 32 days after tooth extractions, and the ZA administration protocol was maintained until the animalsf death. After sacrifice, blood samples were collected for C-terminal cross.linking telopeptide of type I collagen (CTX.1) levels, clinical and radiological findings were recorded.

Results: The bone resorption marker CTX-1 showed a significant difference among the groups. CTX-1 was measured significantly higher in blood samples of Group 2 (4.15 } 0.34; P = 0.001) than Group 1 (3.77 } 0.34; P = 0.0001). No, statistically significant changes were found between Groups 1 and 2 as for clinical and radiological assessment.

Conclusion: This study provides preliminary observations for the  development of an animal model of BRONJ. Although clinical and  radiological findings were not relevant, serum CTX values are reliable biochemical markers for predicting BRONJ and also atraumatic surgical procedures are important to prevent BRONJ.

Key words: Bisphosphonates, bone, osteonecrosis, prevention, serum C-terminal telopeptide level




http://dx.doi.org/10.4103/1119-3077.141417
AJOL African Journals Online